Omkar Speciality Chemicals Transitions Post-CIRP

9 Months Ended 31.12.2025: Total Income ₹0.0939 crore, Loss ₹-1.2562 crore, Basic EPS ₹-0.61

Reader Takeaway: Revival begins with new leadership but weak current financials pose challenges.

What just happened

Omkar Speciality Chemicals Ltd has completed its Corporate Insolvency Resolution Process (CIRP) transition. The National Company Law Tribunal (NCLT) approved its resolution plan on July 31, 2025. The company has also appointed Mr. Dipak Kumar Shaw as its new Chief Executive Officer (CEO) and Mr. Ruhini Kumar Chakraborty as an Independent Director. The resolution plan involves a total amount of ₹26.65 crore.

Why this matters

This marks a significant step for Omkar Speciality Chemicals as it moves out of insolvency proceedings. The appointment of new leadership signals a fresh start for the company's operations and governance. However, the company's recent financial performance remains a concern, with no revenue from operations and a reported loss for the nine months ended December 31, 2025.

The backstory

Omkar Speciality Chemicals had been undergoing CIRP. The NCLT-approved resolution plan aims to provide a financial roadmap for the company's revival. The plan includes a payment of ₹23.14 crore to creditors and ₹3.51 crore for capital expenditure and working capital. The Resolution Applicant has already infused ₹15.0816 crore as of December 2025.

What changes now

With the CIRP concluded and new management in place, the focus will shift to operationalizing the approved resolution plan. The company will work towards restarting its business activities and stabilizing its financial position. The reconstitution of the Audit Committee and Stakeholder's Relationship Committee aims to strengthen corporate governance.

Risks to watch

The primary risks include the company's current lack of revenue from operations and its reported net loss. The auditors have also noted uncertainty regarding the company's ability to continue as a going concern, which depends on the successful implementation of the resolution plan. Historical comparative financial data is unavailable due to the CIRP.

Peer comparison

Detailed peer comparison is difficult as comparative financial figures for Omkar Speciality Chemicals are unavailable due to the CIRP process. The company's immediate focus will be on rebuilding its operational capacity and financial health.

Context metrics (time-bound)

• Resolution Plan Amount: ₹26.65 crore (approved July 31, 2025).
• Creditor Payment: ₹23.14 crore.
• Capex & Working Capital: ₹3.51 crore.
• Capital Infusion by Resolution Applicant: ₹15.0816 crore (as of December 2025).
• 9 Months Ended 31.12.2025: Total Income ₹0.0939 crore, Loss ₹-1.2562 crore.
• Assets (as at 30.09.2025): ₹46.2279 crore.

What to track next

Investors should closely monitor the company's progress in restarting operations, its ability to generate revenue, and its path towards profitability. The successful execution of the resolution plan and future financial disclosures will be key indicators.